EUCTR2017-001678-40-Outside-EU/EEA进行中（未招募）1 期
An extension study of safety of canakinumab in Japanese patients with periodic fever syndromes
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Key Completed Epoch 4 of the CACZ885N2301 study in Japan before the approval of canakinumab in Japan. Written informed consent. Parent or legal guardian's written informed consent and child's assent, if appropriate, are required before any assessment is performed for patients < 20 years of age
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 1
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 3
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Key Any conditions or significant medical problems in which the investigator judges the patient should not enter this extension study
研究者
相似试验
已完成
2 期
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular CarcinomaAdvanced Hepatocellular CarcinomaNCT03586973Takeda34
已完成
不适用
Effectiveness and safety of Satralizumab in Japan; Interleukin-6 receptor inhibition in Neuromyelitis Optica Spectrum Disorders, multicentre medical chart revieweuromyelitis optica spectrum disorderJPRN-UMIN000050027CHUGAI PHARMACEUTICAL CO., LTD.120
已完成
3 期
Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)PsoriasisNCT01952015Novartis Pharmaceuticals12
终止
3 期
A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled AsthmaInadequately Controlled AsthmaNCT02902809AstraZeneca28
已完成
2 期
A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)Candidiasis, EsophagealCandidiasis, InvasiveAspergillosisNCT01165320Merck Sharp & Dohme LLC20